Explore professionally built ETF model portfolios. Discover now →

Advertisement
Advertisement

FMEDvsPTHETF Comparison

ETF 1
FMED

Fidelity Disruptive Medicine ETF

This fund is part of
Multiple Trends
-6.5%
VS
ETF 2
PTH

Invesco DWA Healthcare Momentum ETF

This fund is part of
US Health Care
-3.27%

Fidelity Disruptive Medicine ETF (FMED) belongs to the Multiple Trends segment. Invesco DWA Healthcare Momentum ETF (PTH) is part of the US Health Care segment. FMED's top 1 sector exposures are Healthcare. In contrast, PTH's top sector exposures are Healthcare and Consumer Non-Cyclicals. FMED is less expensive with a Total Expense Ratio (TER) of 0.5%, versus 0.72% for PTH. FMED is up 14.76% year-to-date (YTD) with -$20M in YTD flows. PTH performs worse with 13.21% YTD performance, and +$152M in YTD flows. Run a side-by-side ETF comparison of FMED and PTH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

FMED vs PTH performance and flow charts

Performance

-8.0-6.0-4.0-2.00.02.04.0%Oct 5Oct 12Oct 19Oct 26Nov 2

Cumulative Flows

-4 M-2 M0 M2 M4 M6 M8 MOct 5Oct 12Oct 19Oct 26Nov 2

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 11/05/2026
1M3MYTD1Y3Y5Y
Perf.
FMED
PTH
-4.35%-8.16%
+7.81%-6.32%
+14.76%+13.21%
+19.85%+21.55%
+48.91%+86.20%
n/a+6.30%
Flows
FMED
PTH
-$3M+$9M
-$3M+$58M
-$20M+$152M
-$18M+$162M
-$15M+$107M
--$101M
Volatility and drawdown
3M1Y3Y5Y
Volatility
FMED
PTH
+31.58%+31.90%
+24.11%+28.10%
+20.23%+26.35%
n/a+26.16%
Max drawdown
FMED
PTH
-7.63%-12.72%
-17.78%-12.72%
-19.20%-27.71%
n/a-46.99%
Max drawdown duration
FMED
PTH
69d78d
212d78d
267d353d
n/a1620d
Trading data

Create an account to view trading data

Join for free
FMED
PTH
Last sale
11/6/2026 at 2:30 PM
$57.44
Previous close
11/04/2026
$56.27
Consolidated volume
11/04/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of October 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

FMED
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
FMED
PTH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 11/6/2026 at 2:30 PM
Live
Closed
FMED
PTH
Last price
–
$57.44
1D performance
–
+2.08%
AuM$47.38 M$280.85 M
E/R0.5%0.72%
Characteristics
FMED
PTH
Management strategyActivePassive
ProviderFidelityInvesco
Benchmark-Dorsey Wright Healthcare Technical Leaders Index
N° of holdings7154
Asset class-Equities
Trailing 12m distribution yield
Join
Join
Inception dateJune 12, 2023October 12, 2006
ESGNoNo
Advertisement
Exposure

Countries

FMED
USA
84.97%
Other
15.03%
PTH
USA
90.51%
Other
9.49%

Sectors

FMED
Healthcare
99.49%
Other
0.51%
PTH
Healthcare
99.23%
Other
0.77%

Diversification

FMED

Total weight of top 15 holdings out of 15

47.18%
PTH

Total weight of top 15 holdings out of 15

51.15%

Top 15 holdings

Data as of September 30, 2026
FMED
10X Genomics, Inc.
5.82%
Natera, Inc.
4.47%
Thermo Fisher Scientific, Inc.
4.19%
Danaher Corp.
3.92%
Illumina, Inc.
3.56%
argenx SE
2.96%
Lifestance Health Group, Inc.
2.87%
Revolution Medicines, Inc.
2.86%
Sartorius Stedim Biotech SA
2.72%
Moderna, Inc.
2.62%
Alnylam Pharmaceuticals, Inc.
2.48%
HeartFlow, Inc.
2.39%
Intuitive Surgical, Inc.
2.20%
Cogent Biosciences, Inc.
2.13%
Caris Life Sciences, Inc.
1.99%
PTH
Moderna, Inc.
6.40%
Guardant Health, Inc.
5.11%
Roivant Sciences Ltd.
5.06%
Revolution Medicines, Inc.
4.98%
10X Genomics, Inc.
3.99%
BrightSpring Health Services, Inc.
3.58%
Axsome Therapeutics, Inc.
3.44%
Twist Bioscience Corp.
2.92%
Illumina, Inc.
2.59%
Liquidia Corp.
2.47%
Oruka Therapeutics, Inc.
2.23%
Travere Therapeutics, Inc.
2.23%
Erasca, Inc.
2.15%
Replimune Group, Inc.
2.03%
Axogen, Inc.
1.98%
Frequently asked questions about FMED and PTH

How have the FMED and PTH ETFs performed in 2026?

As of November 5, 2026, FMED is up 14.76% year-to-date (YTD), while PTH has returned 13.21%. That puts FMED better performer ahead so far this year.

Which ETF is attracting more investor money: FMED or PTH?

Year-to-date, the FMED ETF saw -$20M in flows, compared to +$152M for PTH.

Which ETF is more volatile: FMED or PTH?

Over the past year, FMED had a volatility of 24.11%, while PTH experienced 28.1%.

Which ETF is bigger: FMED or PTH?

As of November 5, 2026, FMED holds $47.38 M in assets under management (AUM), while PTH manages $280.85 M.

What sectors do the FMED and PTH ETFs invest in?

FMED leans toward sectors like Healthcare. Meanwhile, PTH focuses on Healthcare.

What are the top holdings of the FMED ETF and PTH ETF?

FMED top holdings include 10X Genomics, Inc., Natera, Inc. and Thermo Fisher Scientific, Inc.. PTH holds in its top three: Moderna, Inc., Guardant Health, Inc. and Roivant Sciences Ltd..

Which ETF is more diversified: FMED or PTH?

FMED holds 71 securities with 47.18% of its assets in the top 15. PTH has 54 securities and a top 15 weight of 51.15%.

Advertisement
Latest news about FMED & PTH
Advertisement
Advertisement
New Report

ETFs’ Next Act: From Access to Selection

Global ETF Survey 2026